Challenging diagnosis: Oligodendroglioma versus extraventricular neurocytoma

Clinical Neuropathology

Volumn 24, Issue 5, 2005, Pages 225-229

  Mut, M ^a,b   Guler Tezel G ^a   Lopes, M B S ^b   Bilginer, B ^a   Ziyal, I ^a   Ozcan O E ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Anaplastic; Extraventricular; FISH; Neurocytoma; Oligodendroglioma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; NEUROEPITHELIOMA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADULT; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; NERVE TISSUE PROTEINS; NEUROCYTOMA; OLIGODENDROGLIOMA; SYNAPTOPHYSIN;

EID: 24644508831     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Allam A, Radwi A, El Weshi A, Hassounah M 2000 Oligodendroglioma: an analysis of prognostic factors and treatment results. Am J Clin Oncol 23: 170-175
2. Berger MS, Rostomily RC 1997 Low-grade gliomas: functional mapping resection strategies, extent of resection and outcome. J Neurooncol 34: 85-101
3. Chinot OL, Honore S, Dufour H, Barrie M, Figarella-Branger D, Muracciole X, Braguer D, Martin PM, Grisoli F 2001 Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. J Clin Oncol 19: 2449-2455
4. Chinot O 2001 Chemotherapy for the treatment of oligodendroglial tumors. Semin Oncol 28 (Suppl 13): 13-18
5. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP 1997 Oligodendrogliomas. Part I: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 34: 37-59
6. Engelhard HH, Stelea A, Mundt A 2003 Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surg Neurol 60: 443-546
7. Gannett DE, Wisbeck WM, Silbergeld DL, Berger MS 1994 The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 30: 567-573
8. Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, Graeber MB, Bauserman S, Buckner JC, Burton J, Riepe R, Tazelaar HD, Nascimento AG, Crotty T, Keeney GL, Pernicone P, Altermatt H 2001 Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60: 248-262
9. Jeremic B, Shibamoto Y, Grujicic D, Milicic B, Stojanovic M, Nikolic N, Dagovic A 1998 Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study. Radiother Oncol 49: 49-54
10. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, Cairncross G 1997 Supratentorial low-grade gliomas in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15: 1294-1301
11. Mork SJ, Lindegaard KF, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R, Harvei S, Ganz J 1985 Oligodendroglioma: incidence and biological behavior in a defined population. J Neurosurg 63: 881-889
12. Olson JD, Riedel E, DeAngelis LM 2000 Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54: 1442-1448
13. Osborn AG 1994 Diagnostic Neuroradiology. Mosby, St. Louis, p 190
14. Perry A, Scheithauer BW, Macaulay RJB, Raffel C, Roth KA, Kros JM 2002 Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61: 947-955
15. Saito A, Nakazato Y 1999 Evaluation of malignant features in oligodendroglial tumors. Clin Neuropathol 18: 61-73
16. Sakata K, Hareyama M, Komae T, Shirato H, Watanabe O, Watarai J, Takai K, Yamada S, Tsuchida E, Sakai K 2001 Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era. Jpn J Clin Oncol 31: 240-245
17. Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF 1996 Prognostic factors in low-grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 61: 291-296
18. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH 1992 Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 76: 424-428
19. Streffer J, Schabet M, Bamberg M, Grote EH, Meyermann R, Voigt K, Dichgans J, Weller M 2000 A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors. J Neurol 247: 297-302
20. Wakabayashi T, Kajita Y, Hatano N, Thompson T, Nagasaka T, Yoshida J 2000 Clinicopathological study of oligodendroglial tumors: the effectiveness of interferon-beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors. Brain Tumor Pathol 17: 29-33
21. Westergaard L, Gjerris F, Klinken L 1997 Prognostic factors in oligodendrogliomas. Acta Neurochir (Wien) 139: 600-605